GlucoTrack
GCTK
2 hedge funds and large institutions have $743K invested in GlucoTrack in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3,915% more capital invested
Capital invested by funds: $18.5K → $743K (+$724K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.24M |
| 2 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
+$53.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$8.97K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.62K |
GCTK Hedge Fund Activity: Q2 2023 in Review
2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2023, worth a combined $743K — up 3,915% from $18.5K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GCTK positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.24M. The largest seller was Boston Financial Management, cutting an estimated $8.97K.
- 2 institutional investors held GlucoTrack (GCTK) as of Q2 2023, up from 0 in Q1 2023.
- Funds reported $743K of GlucoTrack stock for Q2 2023, up 3,915% quarter-over-quarter.
- 2 funds opened new GlucoTrack positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest GlucoTrack buyer in Q2 2023 was Sabby Management, an estimated $1.24M added.
- The largest GlucoTrack seller in Q2 2023 was Boston Financial Management, an estimated $8.97K sold.
Based on aggregated 13F filings for Q2 2023.